Owkin Interview Guide

Owkin is an AI biotechnology company that is revolutionizing the fields of drug discovery and diagnostics through its groundbreaking AI Operating System, known as K. By harnessing advanced AI agents capable of decoding complex biological data, Owkin is committed to enhancing research productivity and empowering pharmaceutical companies to innovate more effectively. The company utilizes the world’s largest federated multimodal patient data network, alongside state-of-the-art technologies, to bridge the intricate relationship between complex biology and innovative treatment solutions. With over $300 million raised from leading investors, including major biopharma firms, Owkin has established itself as a frontrunner at the intersection of artificial intelligence and healthcare, positioning itself to make significant strides in transforming patient outcomes.